Cidara Therapeutics Inc (CDTX)
20.68
+3.23
(+18.51%)
USD |
NASDAQ |
Nov 22, 16:00
18.63
-2.05
(-9.91%)
After-Hours: 16:33
Cidara Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 81.53% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
81.53%
Minimum
Mar 2024
81.53%
Maximum
Mar 2024
81.53%
Average
81.53%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 74.73% |
Arbutus Biopharma Corp | -- |
GlycoMimetics Inc | -- |
FibroGen Inc | 88.57% |
Cue Biopharma Inc | -- |